REGROW Act to do reappearing act?

October 30, 2016 Paul Knoepfler 1

One of the biggest stem cell news stories of 2016 has been the REGROW Act, a bill intended to accelerate investigational stem cell and regenerative medicine therapies to patients by lessening FDA oversight, but in the last couple months REGROW […]